Drugs / Sodium Phenylacetate
Sodium Phenylacetate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | UCEPHAN | — | 1987-12-23 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00004767 | Jan 1985 → ? | inborn disorder of amino acid metabolism | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Phenylacetate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004767 ↗ |
| Known as | NSC-3039 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200358 ↗ |
| Known as | Sodium phenylacetate component of ammonul | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200358 ↗ |
| Known as | Sodium phenylacetate component of ucephan | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200358 ↗ |
| Known as | Sodium phenylacetic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200358 ↗ |
| Modality | Small molecule | — CHEMBL1200358 ↗ |